Leucovorin, also known as folinic acid, is a medication used in several treatment scenarios, primarily related to chemotherapy and folate deficiency.
What is Leucovorin used for?
Leucovorin is administered to reduce the toxicity of methotrexate, a chemotherapy drug, and to enhance the efficacy of certain chemotherapy regimens like those used for colorectal cancer [1]. It is also used to treat megaloblastic anemia caused by folate deficiency when oral administration is not feasible [1].
How does Leucovorin work?
Leucovorin is a reduced form of folic acid. It bypasses the enzyme dihydrofolate reductase (DHFR), which is inhibited by methotrexate. By providing a reduced folate source, leucovorin "rescues" healthy cells from the toxic effects of methotrexate, which targets rapidly dividing cells, including cancer cells and some healthy cells [1]. In colorectal cancer treatment, leucovorin is often used in conjunction with fluorouracil (5-FU) to increase the effectiveness of 5-FU [1].
What are the typical dosages of Leucovorin?
Leucovorin dosage varies significantly depending on the specific use. For instance, in methotrexate rescue protocols, doses can range from 10 mg/m² to 200 mg/m² intravenously or orally every 6 hours for at least 24 doses [1]. When used with fluorouracil for colorectal cancer, common regimens involve leucovorin doses of 200 mg/m² intravenously over 2 hours or 20 mg/m² intravenously [1].
What are the potential side effects of Leucovorin?
Leucovorin is generally well-tolerated. Side effects are typically mild and can include allergic reactions, rash, fever, and nausea [1].
Where can I find information on drug patents and exclusivity?
Information regarding drug patents, including those for medications like leucovorin and its related formulations or uses, can be found on DrugPatentWatch.com [2]. This resource tracks patent expirations and exclusivity periods for pharmaceuticals.
When does Leucovorin's patent protection expire?
Specific patent expiration dates for leucovorin depend on the formulation, manufacturer, and any new intellectual property filings. A general search on resources like DrugPatentWatch.com would provide details on the patent status and exclusivity periods for various leucovorin products [2].
Are there different forms of Leucovorin?
Leucovorin is available in oral and injectable forms. The specific form used depends on the treatment protocol and the patient's ability to take oral medication [1].
How does Leucovorin compare to other folate supplements?
Unlike folic acid, leucovorin is already in a metabolically active form (folinic acid) and does not require reduction by DHFR to become biologically active. This is crucial in contexts like methotrexate rescue, where DHFR is inhibited [1].
What clinical data supports Leucovorin's use?
Extensive clinical trials have established leucovorin's role in reducing methotrexate toxicity and enhancing 5-FU efficacy in various cancers, particularly colorectal cancer [1].
What are patient concerns regarding Leucovorin treatment?
Patients may have concerns about the administration schedule, potential side effects, and how leucovorin interacts with chemotherapy drugs. Understanding the purpose of leucovorin as a protective and potentiating agent is key for patient comprehension [1].
---
Sources:
[1] https://www.drugs.com/mtm/leucovorin.html
[2] https://www.drugpatentwatch.com/